UrgentRx
Latest round
- Series C
Last raised
- Jul 2014
Total raised
- $23M
Investors
- 2
About UrgentRx
Breakthrough Products, Inc. formulates and develops over-the-counter medications for heart attacks and other diseases.
Who invested in UrgentRx
2 investors across 4 rounds
See all investors in UrgentRx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about UrgentRx
Who invested in UrgentRx?
UrgentRx has 2 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has UrgentRx raised?
UrgentRx has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did UrgentRx last raise money?
UrgentRx's most recent round on record is a Series C, in Jul 2014.
What does UrgentRx do?
UrgentRx is a pharmaceuticals company.
Where is UrgentRx headquartered?
UrgentRx is headquartered in Denver, US.
Which VCs invest in companies like UrgentRx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at UrgentRx's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like UrgentRx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.